Similar Search Results

Intersección entre competencia y patentes : hacia un ejercicio pro-competitivo de los derechos de patente en el sector farmacéutico

Rodríguez Gómez, María Juliana - 2020

Persistent link: https://www.econbiz.de/10012433997

Eighteen years after Doha : an analysis of the use of public health TRIPS flexibilities in Africa

Vawda, Yousuf A.; Shozi, Bonginkosi - 2020

Persistent link: https://www.econbiz.de/10012434041

Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products : the case of Sri Lanka's patent law

Fernando, Ruwan - 2023

claimed invention based on a combination or modification of a prior art reference. Sri Lanka, as a developing country, should … look at the development that has taken place in other jurisdictions and adapt the patent law to local conditions when …

Persistent link: https://www.econbiz.de/10014324836

Direito brasileiro da concorrência e acesso à saúde no Brasil : preços exploratórios no setor de medicamentos

Castro, Bruno Braz de - 2022

This paper aims to analyze the interfaces between Brazilian Competition Law and the issue of access to medicines, with special focus on abuses of industrial property rights in their exclusionary and exploitative effects. The paper analyzes the case law of the Brazilian Administrative Council for...

Persistent link: https://www.econbiz.de/10012796800

Brazilian competition law and access to health in Brazil : exploitative pricing in the pharmaceutical sector

Castro, Bruno Braz de - 2022

This paper aims to analyze the interfaces between Brazilian Competition Law and the issue of access to medicines, with a special focus on abuse of industrial property rights and related exclusionary and exploitative effects. The paper analyzes the case law of Brazilian Administrative Council for...

Persistent link: https://www.econbiz.de/10013365665

Misappropriation of genetic resources and associated traditional knowledge: challenges posed by intellectual property and genetic sequence information

Syam, Nirmalya; Romero, Thamara - 2021

Improper acquisition of genetic resources (GRs) and associated traditional knowledge (TK) without prior informed consent and on mutually agreed terms, in accordance with national laws of the country providing the GR and associated TK, as well as without any fair and equitable sharing of the...

Persistent link: https://www.econbiz.de/10012603957

TRIPS flexibilities and TRIPS-plus provisions in the RCEP chapter on intellectual property: how much policy space is retained?

Ido, Vitor Henrique Pinto - 2021

The Regional Comprehensive Economic Partnership (RCEP) was signed on 15 November 2020 by 15 Asian-Pacific countries (ASEAN-Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam-, and China, Japan, South Korea, Australia and New Zealand),...

Persistent link: https://www.econbiz.de/10012604269

Interpreting the flexibilities under the TRIPS agreement

Correa, Carlos María - 2021

While the TRIPS Agreement provides for minimum standards of protection of intellectual property, it leaves a certain degree of policy space for WTO members, whether developed or developing countries, to implement the Agreement's provisions in different manners, to legislate in areas not subject...

Persistent link: https://www.econbiz.de/10012604276

An examination of selected public health exceptions in Asian patent laws

Adachi, Kiyoshi - 2022

This study examines the variations within Asia of two exceptions to patent rights that are commonly justified under … aspirations. The study examines, from a comparative perspective, examples of these respective exceptions in patent legislation in …

Persistent link: https://www.econbiz.de/10013194323

Patent analysis for medicines and biotherapeutics in trials to treat COVID-19

Ravi, Srividya - 2022

support national patent offices and interested parties in developing countries with information that can serve as guidance for … the examination of the claims contained in relevant patents or patent applications. The medicines considered for the … patent analysis in this report are remdesivir, ruxolitinib, favipiravir, molnupiravir and nirmatrelvir, and the …

Persistent link: https://www.econbiz.de/10013194325